Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
83 Cards in this Set
- Front
- Back
Humoral branch of adaptive immunity lecture 21 |
involves antibodies (made by B cells) attacks extracellular pathogens |
|
Cell-cell mediated branch |
involves T cells attacks intracellular pathogens |
|
Class I MHC |
all nucleated cells' present peptides that originate in cytoplasm from intracellular pathogens e.g. CD8 and cytotoxic T cells |
|
Class II MHC |
Professional antigen-presenting cells only present peptides from extracellular paths taken up by phagocytosis (e.g. CD4 and helper t cells) |
|
Helper T cells |
make cytokines, activate B cells, macrophages, or other T cells |
|
Cytotoxic T cells what they do and two things they use |
kill cells expressing foreign antigen using: 1, granzymes and 2. perforins |
|
perforins |
form pores, involved in cytotoxic t cells |
|
granzymes |
induce apoptosis |
|
Cluster of Differentiation (CD) molecules |
membrane proteins that function as coreceptors on immune cells can help determine a cell's identity e.g. helper t cell: CD4 cytotoxic t cell: CD8 |
|
T-cell receptors (TCR's) |
recognize a peptide and an MHC containing said peptide NEED BOTH! bind the peptide are expressed from gene segments rearranged in the thymus |
|
MHC (major histocompatibility complex) |
a collection of genes encoding cell surface molecules for self/nonself recognition |
|
what is human version of MHC? |
human leukocyte antigen (HLA) complex. get 1 from each parent. Closer 2 people are related, more similar HLA important for organ/tissue donation |
|
pathogen |
organism that produces disease |
|
opportunistic pathogen |
infects host with weakened immune system |
|
carrier |
infected individual, potential source of infection (no observable symptoms) |
|
zoonoses |
disease transmitted to humans from animals |
|
vectors |
organisms that transmit disease to humans e.g. mosquitos, fleas, ticks |
|
pathogenicity |
ability to produce disease |
|
virulence |
degree of pathogenicity |
|
latency |
pathogen stops reproducing. Dormant, CAN become active again |
|
pathogenicity islands |
large groups of genes which encode virulence determinants. Present in virulent, absent in non-virulent strains. DNA based composition differs for rest of genome, often flanked by phage or plasmid genes |
|
how is virulence measured? |
Infections dose 50 (ID50): # of paths required to cause clinical disease in 50% of inoculated hosts Lethal dose 50 (LD50): # of paths required to KILL 50% of inoculated hosts |
|
viral attachment example watched in lecture and biochem lecture |
capsid and viral spike proteins mediate viral atta. e.g. GP120 of HIV binds CD4 and CCR5 and Hemagglutinin of influenza binds sialic acid |
|
through what bodily systems can viruses be spread? |
blood, neural, and lymphatic |
|
tropism |
cell tissue, organ specificity determine by host cell receptors |
|
how do viruses evade adaptive immune response? |
block antigen processing, MHC export evade antibody (Antigenic variation) e.g. aa changes in virion spikes, common of RNA viruses |
|
how do viruses evade innate immune response? |
block, breakdown complement,block interferon production |
|
mechanism of bacterial pathogenicity (4 steps) |
1. attachment 2. invasion and spread 3. colonization 4. evade innate and adaptive IRs |
|
#1 bacterial attachment |
pili capsules: Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis certain strains of P. aeruginosa make capsules, called mucoid strains. Is an opportunistic path in burn/cystic fibrosis patients |
|
#2 invasion and spread |
Active penetration of host mucous membranes or epithelium Passive penetration also possible: wounds/bites once below mucous membrane, can spread to deeper tissue or even blood **bacteremia |
|
Bacterial virulence factors (6 of them) |
coagulase streptokinase IgA protease hemolysins siderophores Dnase |
|
coagulase |
clots fibrinogen in plasma, clot protects pathogen |
|
streptokinase |
activates plasmin, digests fibrin clots- pathogen moves from clotted areas |
|
IgA protease |
destroy antibody |
|
hemolysins |
digest RBCs, release iron |
|
siderophores |
released, bind iron |
|
DNase |
lowers viscosity of secretions, spread nutrition |
|
3 ways for bacterial pathogens to evade innate immune responses |
1. capsules-block opsonization, membrane attach complex 2. proteases- degrade C3b (opsonin) or C5a (chemoattractant) 3. type III systems- inject proteins into macrophages & other cells & block TLR signaling and NFkB |
|
3 ways for bacterial pathogens to evade ADAPTIVE immune responses |
capsules IgA proteases Antigenic variation: ∆ cell surface outer membrane or pilli proteins |
|
what are NETs? lecture 22 |
Neutraphil extracellular traps DNA & antimicrobial proteins/enzymes |
|
4 examples of bacterial intracellular paths |
1. Mycobacterium tuberculosis 2. Legionella 3. Chlamydia 4. Listeria monocytogenes |
|
Listeria monocytogenes |
Gram +, food borne path psychrophile, so bad cause fridge doesn't slow growth or kill can cross placenta |
|
what bacteria use the virulence factor biofilm? |
Streptococcus pneumoniae: Otitis Media Pseudomonas in cystic fibrosis lung Staphylococcus & Enterococcus on heart valves -endocarditis |
|
toxins |
substances that damage the host exotoxins (unstable, neutralized by antibodies) and endotoxins |
|
4 types of exotoxins |
1. membrane disrupting 2. superantigens 3. AB 4. specific host site |
|
membrane-disrupting exotoxins |
pore forming exotoxins e.g. Leukocidins and Hemolysins |
|
superantigens (exotoxins) |
cause T cells to overexpress, release cytokines (connects MHC II w/antigen to T cell receptor) failure of multiple host organs TSS caused by Staphylococcus aureus |
|
AB exotoxins |
2 subunits A: toxic effect B: binds target cell receptor many are ADP ribosyltransferases which remove ADP ribose group from NAD& attach it to host cell protein making it fxn abnormally or inactivate |
|
diptheria toxin |
Corynebacterium diptheriae Binds growth factor receptor. enters by endocytosis ADP ribosyltransferase attaches ADP ribose from NAD onto Elongation factor 2 (EF2) |
|
specific host site exotoxins |
many AB toxins are also host site specific |
|
Vibrio cholerae |
ENTEROtoxin ADP ribosylates a host G protein that controls cAMP levels and keeps protein on. increase of cAMP means loss of control of ion flow- massive H20 loss |
|
Clostridium botulinum |
NEUROtoxin blocks Ach release at neuromuscular joints flaccid paralysis |
|
sepsis |
systemic response to microbial infection, elevated temp, heart & respiratory rate, leukocyte count |
|
shock |
sepsis with hypotension (low bp) |
|
bacteremia sepsicemia |
viable bacteria in blood disease associated with pathogens or toxins in blood |
|
Type III secretion systems |
'hand to hand combat' Gram - paths of plants and humans the bad bois all use em |
|
features of type III |
1. injectisome has hollow basal body proteins from bacteria inject into host Injector proteins inject effectors (e.g. yops, sops, and bops their genes are found on pathogenicity island |
|
Targets for typeIII effectors |
1. host cell cytoskeleton (actin) promotes invasion, blocks phagocytosis 2. Host cell signaling (NFkB) blocks cytokine production, induces apoptosis |
|
enteropathogenic E. coli (EPEC) |
TIIISS major cause of infantile diarrhea Binds host cell using bundle-forming pill, the delivers effectors via injectisome MOA includes TIR |
|
Translocated Intimin Receptor (TIR) |
presented on host cell surface, binds bacterial intimin |
|
autoclave stats |
15 lbs/square inch, 121 C 15 min |
|
pasteurization |
63C for 30 min, rapid cool 72C for 15 sec, rapid cool Doesn't sterilize, kills most pathogens e.g. Listeria, Salmonella, Campylobacter |
|
Paul ehrlich |
selective toxicity |
|
Alexander Flemming |
accidentally redsicovered penicillin |
|
florey, chain, and heatley |
purified and injected penicillin into mice which survived |
|
selman Waksman |
cultured 10,000+ strains of soil bacteria and identified streptomycin |
|
targets of antimicrobial agents |
1. cell wall 2. plasma membrane 3. metabolic enzymes 4. Nucleic acid synthesis 5. protein synthesis |
|
penicillins MOA, structural features, spec |
cell wall inhibitors. mostly narrow spec G+ and cidal structural features: B lactam ring and R group (stability and spectrum) MOA: inhibit bacterial Penicillin binding proteins (PBPs) used for transpeptidation |
|
ampicillin |
broad spec G + and G - |
|
where do penicillinases attack and inactivate the drug? |
draw plz B lactam ring bond |
|
penicillin and cephalosporins end result for bacteria? |
stop cell wall synthesis creating osmotic lysis! |
|
vancomycin MOA |
binds terminal D-alanine on NAM, also blocking transpeptidation |
|
where in the cell are Nag and NAM made? |
cytoplasm, carrier moves them across membrane to become part of cell wall |
|
Bacitracin MOA |
blocks carrier of NAG & NAM across membrane * topically applied e.g. neosporin |
|
plasma membrane inhibitors 3 types |
1. polymyxins 2. Miconazole 3. Nystalin |
|
Polymixins MOA, spec |
cidal, narrow spec mostly G- bind LPS, disrupt outer/plasma membrane e.g. colistin |
|
Miconazole, MOA, conditions treated |
blocks sterol synthesis treats athletes foot/candida yeast infections |
|
Nystalin MOA, condition |
binds sterols candida yeast infections |
|
4 types of protein synthesis inhibitors |
1. AMinoglucosides 2. Tetracyclines 3. Macrolides 4. Chloramphenicol |
|
aminoglycosides MOA, 2 examples of drugs |
cidal bind 30s, cause misreading of mRNA codons e.g. streptomycin, kanamycin |
|
tetracycline MOA |
static also bind 30s, block tRNA + aa binding to A site |
|
macrolides MOA |
static Bind 23s rRNA of 50s, block peptide bond formation |
|
chloramphenicol MOA |
same MOA as macrolides toxic, only used in life-threatening situations |